23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility

Ann Intern Med. 2017 Jul 18;167(2):125-126. doi: 10.7326/M17-1045. Epub 2017 May 30.

Authors

Julia Wynn¹, Wendy K Chung¹

Affiliation

¹ From Columbia University, New York, New York.

PMID: 28554190
DOI: 10.7326/M17-1045

No abstract available

MeSH terms

Direct-To-Consumer Screening and Testing*
Genetic Predisposition to Disease
Genetic Testing*
Genotype
Humans
Marketing
United States
United States Food and Drug Administration